Molecular Basis of Pancreatic Neuroendocrine Tumors.

Autor: Maluchenko, Alesia, Maksimov, Denis, Antysheva, Zoia, Krupinova, Julia, Avsievich, Ekaterina, Glazova, Olga, Bodunova, Natalia, Karnaukhov, Nikolay, Feidorov, Ilia, Salimgereeva, Diana, Voloshin, Mark, Volchkov, Pavel
Zdroj: International Journal of Molecular Sciences; Oct2024, Vol. 25 Issue 20, p11017, 22p
Abstrakt: Pancreatic neuroendocrine tumors (NETs) are rare well-differentiated neoplasms with limited therapeutic options and unknown cells of origin. The current classification of pancreatic neuroendocrine tumors is based on proliferative grading, and guides therapeutic strategies, however, tumors within grades exhibit profound heterogeneity in clinical manifestation and outcome. Manifold studies have highlighted intra-patient differences in tumors at the genetic and transcriptomic levels. Molecular classification might become an alternative or complementary basis for treatment decisions and reflect tumor biology, actionable cellular processes. Here, we provide a comprehensive review of genomic, transcriptomic, proteomic and epigenomic studies of pancreatic NETs to elucidate patterns shared between proposed subtypes that could form a foundation for new classification. We denote four NET subtypes with distinct molecular features, which were consistently reproduced using various omics technologies. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Nepřihlášeným uživatelům se plný text nezobrazuje